ClinicalTrials.Veeva

Menu

Rheumatoid Arthritis Satisfaction Outcome Research

Pfizer logo

Pfizer

Status

Completed

Conditions

Rheumatoid Arthritis

Study type

Observational

Funder types

Industry
Other

Identifiers

NCT03703817
A3921304
RA SATISFACTION (Other Identifier)

Details and patient eligibility

About

RA satisfaction OR: This study aim to compare treatment satisfaction and quality of life between patients who have been using tofacitinib citrate and patients who have been using adalimumab for 6 months or more and less than 2 year in RA treatment of rheumatoid arthritis.

Full description

RA satisfaction OR: This study aim to compare treatment satisfaction and quality of life between patients who have been using tofacitinib citrate and patients who have been using adalimumab for 6 months or more and less than 2 year in RA treatment of rheumatoid arthritis.

Study design: Non-interventional, multi-centers, cross-sectional study

Enrollment

421 patients

Sex

All

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Patients aged 19 years or older
  2. Patients diagnosed with RA
  3. Treatment groups:
  1. Tofacitinib citrate users: Patients currently on treatment with tofacitinib citrate in RA therapy for 6 months or more 2) Adalimumab users: Patients currently on treatment with adalimumab in the RA therapy for 6 months or more 4. Reading and writing with enough proficiency to complete assessment instruments in Korean

Exclusion criteria

  1. Patients currently on tofacitinib citrate or adalimumab for 2 year or more
  2. Patients taking Azathioprine and cyclosporine
  3. Patients participating in other drug interventional study
  4. Patients who have been treated with bDMARDs except Rheumatoid arthritis.

Trial design

421 participants in 2 patient groups

tofacitinib citrate users
Description:
patients who have been using tofacitinib citrate for 6 months or more and less than 2 year in RA patients
adalimumab users
Description:
patients who have been using adalimumab for 6 months or more and less than 2 year in RA patients

Trial documents
2

Trial contacts and locations

23

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems